Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A patent review of peptidylarginine deiminase 4 (PAD4) inhibitors (2014–present)

Journal article

Aiken SG. et al, (2025), Expert Opinion on Therapeutic Patents, 1 - 11

Drug repurposing in amyotrophic lateral sclerosis (ALS)

Journal article

Carroll E. et al, (2025), Expert Opinion on Drug Discovery, 1 - 18

Identification and characterization of human KALRN mRNA and Kalirin protein isoforms.

Journal article

Mould AW. et al, (2024), Cerebral cortex (New York, N.Y. : 1991), 34

Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor.

Journal article

Xiong Y. et al, (2024), Journal of medicinal chemistry

Structural Premise of Selective Deubiquitinase USP30 Inhibition by Small-Molecule Benzosulfonamides

Journal article

O'Brien DP. et al, (2023), Molecular & Cellular Proteomics, 22, 100609 - 100609

Open drug discovery in Alzheimer's disease.

Journal article

Axtman AD. et al, (2023), Alzheimer's & dementia (New York, N. Y.), 9

Load More